varenicline has been researched along with Atheroma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Inada, K; Kanaoka, Y; Kataoka, Y; Koga, M; Nakao, Y; Okamoto, M; Takayama, S; Yamauchi, A | 1 |
| Inada, K; Kanaoka, Y; Kataoka, Y; Koga, M; Omine, S; Yamauchi, A | 1 |
| Kanaoka, Y; Kataoka, Y; Koga, M; Kubo, N; Ohishi, K; Ohkido, Y; Sugiyama, K; Yamauchi, A | 1 |
3 other study(ies) available for varenicline and Atheroma
| Article | Year |
|---|---|
Varenicline aggravates atherosclerotic plaque formation in nicotine-pretreated ApoE knockout mice due to enhanced oxLDL uptake by macrophages through downregulation of ABCA1 and ABCG1 expression.
Topics: Animals; ATP Binding Cassette Transporter 1; ATP Binding Cassette Transporter, Subfamily G, Member 1; Down-Regulation; Gene Expression Regulation; Lipoproteins, LDL; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout, ApoE; Nicotine; Plaque, Atherosclerotic; RAW 264.7 Cells; Smoking Cessation Agents; Varenicline | 2020 |
Hesperidin blocks varenicline-aggravated atherosclerotic plaque formation in apolipoprotein E knockout mice by downregulating net uptake of oxidized low-density lipoprotein in macrophages.
Topics: Animals; Apolipoproteins E; ATP Binding Cassette Transporter 1; ATP Binding Cassette Transporter, Subfamily G, Member 1; Cardiovascular Diseases; CD36 Antigens; Down-Regulation; Hesperidin; Lipoproteins, LDL; Macrophages; Mice; Mice, Knockout; Plaque, Atherosclerotic; RAW 264.7 Cells; Scavenger Receptors, Class E; Varenicline | 2020 |
Varenicline aggravates plaque formation through α7 nicotinic acetylcholine receptors in ApoE KO mice.
Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Apolipoproteins E; Benzazepines; Body Weight; Cardiovascular Diseases; Cholesterol; Disease Models, Animal; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotinic Agonists; Plaque, Atherosclerotic; Quinoxalines; Varenicline | 2014 |